Chemoinformaics analysis of 3-METHYL-5-PHENYLISOTHIAZOLE
| Molecular Weight | 175.256 | nRot | 1 |
| Heavy Atom Molecular Weight | 166.184 | nRig | 11 |
| Exact Molecular Weight | 175.046 | nRing | 2 |
| Solubility: LogS | -3.889 | nHRing | 1 |
| Solubility: LogP | 3.214 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 9 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 11 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 11 |
| nHA | 2 | APOL | 26.7011 |
| nHD | 0 | BPOL | 12.6289 |
| QED | 0.649 |
| Synth | 2.114 |
| Natural Product Likeliness | -1.245 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.363 |
| MDCK | 0.0000182 |
| BBB | 0.262 |
| PPB | 0.962567 |
| VDSS | 1.173 |
| FU | 0.0317931 |
| CYP1A2-inh | 0.982 |
| CYP1A2-sub | 0.863 |
| CYP2c19-inh | 0.925 |
| CYP2c19-sub | 0.249 |
| CYP2c9-inh | 0.596 |
| CYP2c9-sub | 0.712 |
| CYP2d6-inh | 0.442 |
| CYP2d6-sub | 0.627 |
| CYP3a4-inh | 0.201 |
| CYP3a4-sub | 0.317 |
| CL | 2.409 |
| T12 | 0.247 |
| hERG | 0.056 |
| Ames | 0.718 |
| ROA | 0.733 |
| SkinSen | 0.924 |
| Carcinogencity | 0.817 |
| EI | 0.92 |
| Respiratory | 0.469 |
| NR-Aromatase | 0.026 |
| Antiviral | No |
| Prediction | 0.825226 |